ATM p.G2023R has been previously reported in breast cancer patients from Brazil; however, we obtained the same mutation on exon 41, whereas, in the Brazilian cohort, the same mutation was reported on exon 42 (Mangone et al., 2015). This evidence concerns the gene ATM and breast carcinoma.